Biogen Change in AR remained flat by 0.0% to -$25.68M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 53.8%, from -$55.58M to -$25.68M. Over 2 years (FY 2022 to FY 2025), Change in AR shows a downward trend with a -32.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease is generally positive as it indicates faster collection of cash from customers.
This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...
Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.
change_in_accounts_receivable| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$174.30M | -$167.00M | $87.50M | $0.00 | $42.20M | $93.90M | -$77.20M | -$55.58M | -$55.58M | -$55.58M | -$55.58M | -$25.68M | -$25.68M | -$25.68M | -$25.68M |
| QoQ Change | — | +4.2% | +152.4% | -100.0% | — | +122.5% | -182.2% | +28.0% | +0.0% | +0.0% | +0.0% | +53.8% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +100.0% | — | +156.2% | -188.2% | +28.0% | — | — | — | +53.8% | +53.8% | +53.8% | +53.8% |